Category

• Business1
• Pipeline1
• Research1

Organizations

• Bausch + Lomb57
• Eyes On Eyecare38
• Alcon, Inc.33
• American Optometric Association30
• Glaukos24
• Harrow24
• Regeneron19
• Aldeyra Therapeutics18
• Coopervision18
• Sight Sciences18

Tags

• Glaucoma3
• Ascrs1
• Iols1
• Ocular Hypertension1
• Clinical Trials1
• Finance1
• Financial1
• Glaucoma Medications1
• Ophthalmology1
• Technology1

• Organizations: SpyGlass Pharma, Inc✕

Clear all

Research

SpyGlass Pharma reports positive 18-month data on glaucoma sustained delivery system

Presented at ASCRS, new findings show promising visual outcomes and IOP lowering following sustained-release delivery of bimatoprost.

Business

SpyGlass Pharma secures $90M in financing for chronic ophthalmic disease drug delivery platform

First-of-its-kind controlled-release platform is designed to significantly lower IOP.

Pipeline

SpyGlass Pharma releases 6-month data from first-in-human trial for glaucoma

Breakthrough drug delivery platform demonstrates significant IOP lowering.